Percutaneous Transvenous Atrial Fibrillation Ablation and Stroke

Similar documents
Atrial Fibrillation: Catheter Ablation with New Technologies, Improving Quality of Life and Outcomes in Various Disease States

Role of LAA isolation in AF cure

Raphael Rosso MD, Yuval Levi Med. Eng., Sami Viskin MD Tel Aviv Sourasky Medical Center

The EP Perspective: Should We Do Hybrid Ablation, and Who Should We Do It On?

Atrial Fibrillation Ablation: in Whom and How

Linear Ablation Should Not Be a Standard Part of Ablation in Persistent AF. Disclosures. LA Ablation vs. Segmental Ostial Ablation With PVI for PAF

Combined catheter ablation and left atrial appendage closure as a. treatment of atrial fibrillation

Devices to Protect Against Stroke in Atrial Fibrillation

The Future of Catheter Ablation

Catheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes

Ruolo della ablazione della fibrillazione atriale nello scompenso cardiaco

A Cryo Anatomical Procedure to Everyone? Saverio Iacopino, FACC, FESC

Ablation of persistent AF Is it different than paroxysmal?

20% 10/9/2018. Fluoroless Ablation relinquishing an old habit. Prevalence of Atrial Fibrillation. Atrial Fibrillation is a Progressive Disease

Debate-STAR AF 2 study. PVI is not enough

Renal Sympathetic Denervation Beyond Hypertension: Therapy for Arrhythmias and for Autonomic Nervous System Dysfunction?

Κατάλυση παροξυσμικής κολπικής μαρμαρυγής Ποια τεχνολογία και σε ποιους ασθενείς; Χάρης Κοσσυβάκης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ.

Does AF Ablation Lower Stroke Risk? Hugh Calkins MD Professor of Medicine Director of Electrophysiology Johns Hopkins Medical Institutions

Catheter ablation of AF Where do we stand, where do we go?

Interventional solutions for atrial fibrillation in patients with heart failure

Rotor Mapping A FIRM Foundation Exists

PVI and What Else for Persistent AF Lessons Learned from STAR AF 2 CCCEP 2015 October 31, New York

The Future. Sanjiv M. Narayan, MD, PHD, FHRS, FRCP Professor of Medicine, University of California San Diego San Diego Veterans Affairs Medical Center

AF Ablation in 2015 Why, Who, What and How? Steve Wilton ACC Rockies, Banff March 10, 2015

Pulmonary Vein Isolation for AF RF or Cryo? Dr. Yuen Ho Chuen Princess Margaret Hospital

Catheter Ablation of Atrial Fibrillation

In Whom and When Should Atrial Fibrillation Ablation be Considered?

Fibrillation Atriale Paroxystique : ablation, résultats, complications

Catheter ablation of atrial fibrillation: Indications and tools for improvement of the success rate of the method. Konstantinos P.

Mapping and Ablation in AF: how can we evaluate the lesion formation?

Indicatie voor ablatie bij voorkamerfibrillatie. Andrea Sarkozy Cardiologie Universitair Ziekenhuis Antwerpen

Contemporary Strategies for Catheter Ablation of Atrial Fibrillation

Laser balloon ablation for AF: A systematic review and meta analysis

Surgical Ablation for Lone AF: What have we learned after 30 years?

Percutaneous Epicardial LAA Closure: When Does it Make Sense?

Ablation Should Not Be Used as Primary Therapy for Treatment of Patients with Atrial Fibrillation

Individualised strategy approach to AF ablation

Outcomes of AF Ablation

Catheter Ablation of Atrial Fibrillation Persistent Atrial Fibrillation Catheter Ablation : where are we?

Ablation Lesion Assessment

Post-ablation Management: Drug therapy, Anticoagulation and long-term Monitoring

Left Atrial Appendage Closure: The Rationale

Can the UK afford ablation for persistent AF? cost efficacy analysis. Dr Derick Todd Liverpool Heart & Chest Hospital

Catheter ABlation vs ANtiarrhythmic Drug Therapy in Atrial Fibrillation (CABANA) Trial

New technology to minimize radiation

Long Standing Persistent AF ; CPVI is enough for it

Balloon and Mesh Catheter Ablation of Pulmonary Veins

Ablation Index : A new standard for Safety and Efficacy. Dr Franck Halimi Hôpital Privé Parly 2 Le Chesnay, France

Atrial Fibrillation: Rate vs. Rhythm. Michael Curley, MD Cardiac Electrophysiology

Despite significant improvements in catheter ablation. Original Article

Surgical Ablation: Which Lesion Set for Which Patient?

Should hybrid ablation be the standard of care instead of transcatheter ablation techniques?

Catheter Ablation of Atrial Fibrillation Strategy and Outcome Predictors Shih-Ann Chen MD

Fibrillazione atriale e scompenso: come interrompere il circolo vizioso.

Innovations in AF Management

ABLATION TECHNIQUES FOR ATRIAL FIBRILLATION

Ablation of atrial fibrillation Techniques and workflow in AF rotors. G. Hindricks and Ph. Sommer

Left Atrial Appendage Occlusion in the Era of Novel Anticoagulants

Catheter Ablation of Atrial Fibrillation in Patients with Prosthetic Mitral Valve

CATHETER ABLATION FOR ATRIAL FIBRILLATION WHEN and HOW

Despite significant improvements in catheter ablation. Original Article

Progression of atrial fibrillation: can we prevent it? Early catheter ablation will stop progression of atrial fibrillation pro

Catheter Ablation of Long-Standing Persistent Atrial Fibrillation

Atrial fibrillation and advanced age

Is cardioversion old hat? What is new in interventional treatment of AF symptoms?

AF Ablation in Patients with Heart Failure

Stand alone maze: when and how?

Catheter ablation of scar-related atypical atrial flutter

Time to recurrence of atrial fibrillation influences outcome following catheter ablation

Implantable Cardiac Monitors for Atrial Fibrillation (AF) Detection: Ready for Routine Use?

CARDIOLOGY GRAND ROUNDS

Jesus M. Paylos, C. Ferrero, L. Azcona, A. Morales, M. A. Vargas, L. Lacal, V. Gomez Tello.

EHRA/EUROPACE 2011 Madrid, Spain June

AF :RHYTHM CONTROL BY DR-MOHAMMED SALAH ASSISSTANT LECTURER CARDIOLOGY DEPARTMENT

How Should we Select Patients for Catheter Ablation? Douglas Esberg, MD, FHRS

How atrial fibrillation should be treated in the heart failure patient?

University of Groningen. Ablation of atrial fibrillation de Maat, Gijs Eduard

Catheter ablation in AF patients with heart failure. What is possible?

Trial design and selection criteria

Επιπλοκές κατάλυσης πνευµονικών φλεβών

National Heart Foundation of Australia consensus statement on catheter ablation as a therapy for atrial fibrillation

CLINICAL COMPENDIUM. The HeartLight Endoscopic Ablation System Putting a New Level of PVI Precision Close at Hand. CardioFocus.com

Can Catheter Ablation of AF Reduce the Risk of Stroke? CCCEP 2015 October 31, 2015

SEVEN YEARS OF CRYO-BALLOON CATHETER ABLATION

Atrial fibrillation (AF), the most sustained cardiac arrhythmia

How to Distinguish Focal Atrial Tachycardia from Small Circuits and Reentry

Ablazione della fibrillazione atriale: dubbi presenti e prospettive future

CLINICAL COMPENDIUM. The HeartLight Endoscopic Ablation System Putting a New Level of PVI Precision Close at Hand. CardioFocus.com

UNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate

AF ABLATION Concepts and Techniques

Electrical Reconnection Following PVI is Contingent on Contact Force during Initial Treatment Results From the EFFICAS I Study

Managing Atrial Fibrillation in the Heart Failure Patient

Atrial Fibrillation and Heart Failure

2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation

Scompenso cardiaco e F A : ruolo della ablazione transcatetere. Prof. Fiorenzo Gaita

Storia dell ablazione della fibrillazione atriale: da dove siamo partiti, dove siamo, dove andremo. Prof. Fiorenzo Gaita

The HISTORIC-AF TRIAL

EP Clinical Research Program Summary. Daniel L Lustgarten MD PhD Associate Professor The University of Vermont School of Medicine

Long-Term Outcomes After Cryoballoon Pulmonary Vein Isolation

Catheter Ablation for Persistent Atrial Fibrillation

Transcription:

Percutaneous Transvenous Atrial Fibrillation Ablation and Stroke Vivek Y. Reddy, MD Helmsley Trust Professor of Medicine Director, Cardiac Arrhythmia Service The Mount Sinai Hospital

Disclosures Grant support and/or Consultant: ACT, Acutus Medical, Apama Medical, Biosense-Webster, Boston Scientific, Cardiofocus, Coherex, Endosense, Magnetecs, Medtronic, Philips, St Jude Medical, VytronUS I will be discussing off-label use of catheter ablation devices.

Paroxysmal AF: Catheter Ablation

Treatment success (%) Success of Catheter Ablation: Comparison to Medications Thermocool IDE Study STOP-AF Study 100 30 days 63% 80 60 CRYO 69.9% 114/163 17% 40 20 P<0.001) Blanked DRUG Rx 7.3% 6/82 Wilber et al, JAMA, 2010 0 0 100 200 300 400 500 Days Packer et al, JACC, 2013

Role of Catheter Ablation: 2012 ESC/EHRA Guideline Update Camm et al Eur Heart J 2012; 33:2719.

Paroxysmal AF: Why does ablation fail?

3 mos 24 hrs Baseline Paroxysmal AF: Why does ablation fail? Red = DE-T1/scar Blue = T2/edema Arujuna A, et al: Circ Arry, 5:691 (2012)

How often does PV reconnection occur? The GAP-AF Trial PVI Group PV Isolation Paroxysmal AF EP Study (3 mo) Were PV isolated? Gap Group Allow PV Reconnection Outcome AF Recurrence at 90 days: PVI Group: 61.2%, p<0.001 Gap Group: 79.2% Patients with any PV reconnections at 3 months Gap Group: 89% PVI Group: 70% Breithardt G et al. Herz 33:548-555, 2008 KHKuck et al. Presented at the German Cardiac Society, March 2013

Rate of Durable PVI in the Modern Era Methodological Changes we Instituted Catheter Stability: GA / JET Ventilation (Natale, Schwartzman, Marchlinski) Deflectable sheath to maximize tissue contact (Hindricks) Good Lesions : ICE Imaging of tissue contact (Marchlinski, Natale, Mangrum) How do these changes affect the durability of PVI?: Attention to impedance drop during ablation Examined our rate of PV reconnection in patients undergoing redo procedures after a first-ever ablation procedure Outcome: 93% of PV pairs remain isolated 86% of patients had all PVs isolated Circumferential tissue necrosis: PV isolation as ipsilateral vein pairs No Visual Gaps: Full encircling ablation despite PVI prior to encircling Contiguous lesions (Visually-Guided Laser, EFFICAS 1 & 2) Miller MA, Dukkipati S, Koruth J, d Avila A, Reddy VY AHA 2011 Minimize chance of dormant conduction: Longitudinal redundancy of the lesion set After PVI, additional ablation at sites of pace-capture (Michaud, Hindricks) Use Adenosine to identify dormant conduction (Arentz, Nattel) Use Isuprel to identify non-pv Triggers (Marchlinski, Natale)

How to improve AF ablation outcome? New Technology S.Dukkipati / P.Neuzil / A.d Avila / V.Reddy, Circulation Arrhy 3;266-273 (2010)

Persistent AF: Catheter Ablation

Persistent AF: Catheter Ablation Normal AF EGM: CFAE:

Persistent AF: Why does ablation fail?

Atypical Flutter: Multielectrode Mapping Patel & Reddy, Circ-Arry, 2008;1:14-22.

Ablation in Persistent AF: What is the future? Old Approach: CFAE Ablation Normal AF EGM: CFAE: New Approach: Identifying AF Rotors/Sources 1. FIRM: Focal Impulse and Rotor Modulation 2. Panoramic Body Surface Mapping

Case Example: 54y Pers AF despite prior extensive LA ablation RAA Courtesy: M.Haissagurre

So Ablation improves symptoms. Does ablation decrease stroke risk?

Stroke Risk After Catheter Ablation? 4,212 consecutive AF ablation pts 16,848 age/gender matched pts w/ AF 16,848 age/gender matched pts w/o AF AF + Ablation No AF AF Themistoclakis et al, JACC, 2010 Bunch et al, J Cardiovasc Electrophysiol 2011

Stroke Incidence After MAZE Buber,et al J Am Coll Cardiol 2011; 58:1614 21.

Catheter Ablation as Stroke Prophylaxis? Guidelines 2006 ACC/AHA/ACC Guidelines 1. Warfarin is recommended for all patients for at least 2 months after an AF ablation procedure. 2. Decisions regarding the use of Warfarin more than 2 months after ablation should be based on the patient s risk factors for stroke and not on the presence or type of AF. 3. Discontinuation of Warfarin therapy post-ablation is generally not recommended in patients who have a CHADS 2 score 2. 2010/2012 ESC/EHRA Guidelines 2012 HRS/EHRA/ECAS Consensus Statement

Final Thoughts: Catheter Ablation Catheter Ablation of Paroxysmal AF Goal is permanent PV Isolation Catheter Ablation of Persistent AF Ideally, ablate while still paroxysmal Good outcome but with multiple procedures Catheter ablation of AF may be sufficient for stroke prevention in lower risk patients Long-term freedom from recurrent AF is not low enough in high-risk patients Need prospective randomized data!!!